{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:41:32Z","timestamp":1793450492352,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009020","name":"University of South China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009020","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117187","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:19:15Z","timestamp":1722352755000},"page":"117187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Original antigenic sin: A potential double-edged effect for vaccine improvement"],"prefix":"10.1016","volume":"178","author":[{"given":"Xuan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangchen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-8124","authenticated-orcid":false,"given":"Xiaohong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1676","key":"10.1016\/j.biopha.2024.117187_bib1","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0248","article-title":"Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza","volume":"370","author":"Zarnitsyna","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"7798","key":"10.1016\/j.biopha.2024.117187_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117187_bib3","unstructured":"Oganization W.H.: Coronavirus Disease (COVID-19): Weekly Epidemiological, Update 1. In: World Health Organization. vol. Geneva; 2020."},{"issue":"8","key":"10.1016\/j.biopha.2024.117187_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6692","key":"10.1016\/j.biopha.2024.117187_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/28860","article-title":"Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes","volume":"394","author":"Klenerman","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2024.117187_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00056-21","article-title":"HT. E: original antigenic sin: the downside of immunological memory and implications for COVID-19","volume":"6","author":"Brown","year":"2021","journal-title":"mSphere"},{"issue":"316","key":"10.1016\/j.biopha.2024.117187_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.117187_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.98.6.641","article-title":"Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus","volume":"98","author":"Davenport","year":"1953","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.117187_bib9","first-page":"572","article-title":"On the doctrine of original antigenic sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc. Am. Philos. Soc."},{"issue":"22","key":"10.1016\/j.biopha.2024.117187_bib10","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117187_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028803","article-title":"What are the primary limitations in B-cell affinity maturation, and how much affinity maturation can we drive with vaccination? Is affinity maturation a self-defeating process for eliciting broad protection?","volume":"10","author":"Stamper","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2024.117187_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-981-15-3532-1_4","article-title":"Germinal center reaction","volume":"1254","author":"Huang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117187_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005806","article-title":"Antibodies with 'original antigenic sin' properties are valuable components of secondary immune responses to influenza viruses","volume":"12","author":"Linderman","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2024.117187_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0092-8674(87)90073-0","article-title":"Analysis of somatic mutation and class switching in naive and memory b cells generating adoptive primary and secondary responses","volume":"48","author":"Siekevitz","year":"1987","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2024.117187_bib15","article-title":"Molecular analysis of original antigenic sin I. Clonal selection, somatic mutation, and isotype switching during a memory B cell response","volume":"170","author":"F","year":"1989","journal-title":"J. Med."},{"issue":"7821","key":"10.1016\/j.biopha.2024.117187_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","article-title":"A perspective on potential antibody-dependent enhancement of SARS-CoV-2","volume":"584","author":"Arvin","year":"2020","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.biopha.2024.117187_bib17","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1306333110","article-title":"Original antigenic sin in dengue revisited","volume":"110","author":"Zompi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117187_bib18","unstructured":"Janeway C.A., P. T: Immunobiology. 3rd; 1997."},{"key":"10.1016\/j.biopha.2024.117187_bib19","first-page":"171","article-title":"Prediction of an HLA B8-restricted influenza epitope by motif","volume":"79","author":"Suhrbier","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2024.117187_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-3024.1993.tb00599.x","article-title":"'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion","volume":"15","author":"Good","year":"1993","journal-title":"Parasite Immunol."},{"issue":"21","key":"10.1016\/j.biopha.2024.117187_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150613","article-title":"Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19","volume":"131","author":"Aguilar-Bretones","year":"2021","journal-title":"J. Clin. Invest"},{"issue":"20","key":"10.1016\/j.biopha.2024.117187_bib22","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.biopha.2024.117187_bib23","first-page":"521","article-title":"cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine","volume":"58","author":"Serum","year":"2009","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2024.117187_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038786","article-title":"Original antigenic sin: how original? How sinful?","volume":"11","author":"Yewdell","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117187_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162192","article-title":"Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity","volume":"133","author":"Aguilar-Bretones","year":"2023","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.biopha.2024.117187_bib26","first-page":"453","article-title":"FT: interpretations of influenza antibody patterns of man","volume":"41","author":"Davenport","year":"1969","journal-title":"Bull. World Health Organ"},{"issue":"4","key":"10.1016\/j.biopha.2024.117187_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/mab.2020.0029","article-title":"A novel hypothesis for original antigenic sin in the severe disease of SARS-CoV-2 infection","volume":"39","author":"Kohler","year":"2020","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"10.1016\/j.biopha.2024.117187_bib28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3389\/fimmu.2020.01120","article-title":"Antibody dependent enhancement due to original antigenic sin and the development of SARS","volume":"11","author":"Fierz","year":"2020","journal-title":"Front Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.117187_bib29","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ijantimicag.2010.06.019","article-title":"Dengue conundrums","volume":"36","author":"Gibbons","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.biopha.2024.117187_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.biopha.2024.117187_bib31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.chom.2021.06.009","article-title":"Antibody and B cell responses to SARS-CoV-2 infection and vaccination","volume":"29","author":"Roltgen","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2024.117187_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2023.05.007","article-title":"Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin","volume":"259","author":"Kan","year":"2023","journal-title":"Immunol. Lett."},{"issue":"25","key":"10.1016\/j.biopha.2024.117187_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400202121","article-title":"A speed limit on serial strain replacement from original antigenic sin","volume":"121","author":"McGough","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117187_bib34","unstructured":"Lumley S.F., O\u2019Donnell D., Stoesser N.E., Matthews P.C., Howarth A., Hatch S.B., Marsden B.D., Cox S., James T., Warren F.J.M.: Antibodies to SARS-CoV-2 are associated with protection against reinfection. 2020:2020.2011. 2018.20234369."},{"key":"10.1016\/j.biopha.2024.117187_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"al. e: original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.biopha.2024.117187_bib36","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20130212","article-title":"Immune history shapes specificity of pandemic H1N1 influenza antibody responses","volume":"210","author":"Li","year":"2013","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117187_bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.1102124","article-title":"Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells","volume":"188","author":"Zompi","year":"2012","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.biopha.2024.117187_bib38","doi-asserted-by":"crossref","first-page":"8107","DOI":"10.1073\/pnas.1324197111","article-title":"Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus","volume":"111","author":"Worobey","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117187_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/314538","article-title":"Analysis of the Original Antigenic Sin Antibody Response to the Major Outer Membrane Protein of Chlamydia trachomatis","volume":"179","author":"D.Berry","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.117187_bib40","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.cell.2022.03.038","article-title":"mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron","volume":"185","author":"Gagne","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117187_bib41","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3389\/fimmu.2017.01845","article-title":"Thyroid autoantibodies display both \"Original Antigenic Sin\" and epitope spreading","volume":"8","author":"McLachlan","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117187_bib42","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"112","key":"10.1016\/j.biopha.2024.117187_bib43","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2015.0627","article-title":"A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants","volume":"12","author":"Ndifon","year":"2015","journal-title":"J. R. Soc. Interface"},{"issue":"34","key":"10.1016\/j.biopha.2024.117187_bib44","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1073\/pnas.0912458109","article-title":"Strategies to alleviate original antigenic sin responses to influenza viruses","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117187_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940715","article-title":"A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects","volume":"13","author":"Dotiwala","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117187_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/infdis\/jiz089","article-title":"Original antigenic sin shapes the immunological repertoire evoked by human cytomegalovirus glycoprotein B\/MF59 vaccine in seropositive recipients","volume":"220","author":"Baraniak","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"159","key":"10.1016\/j.biopha.2024.117187_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0258-2020","article-title":"Influenza vaccination: protecting the most vulnerable","volume":"30","author":"Tanner","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.biopha.2024.117187_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1382911","article-title":"Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination - kinetics of plasma antibodies, plasmablasts and memory B cells","volume":"15","author":"Wietschel","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117187_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355949","article-title":"SARS-CoV-2 spike-reactive na\u00efve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination","volume":"15","author":"Teng","year":"2024","journal-title":"Front. Immunol."},{"issue":"10318","key":"10.1016\/j.biopha.2024.117187_bib50","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2024.117187_bib51","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1038\/s41467-022-33169-0","article-title":"Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil","volume":"13","author":"Ranzani","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.117187_bib52","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1038\/s41467-022-31379-0","article-title":"Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial","volume":"13","author":"Kaabi","year":"2022","journal-title":"Nat. Commun."},{"issue":"10324","key":"10.1016\/j.biopha.2024.117187_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(22)00094-0","article-title":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study","volume":"399","author":"Costa Clemens","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2024.117187_bib54","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1016\/S2214-109X(22)00112-7","article-title":"Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study","volume":"10","author":"Jara","year":"2022","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.biopha.2024.117187_bib55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-024-03295-1","article-title":"Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial","volume":"22","author":"Erfanpoor","year":"2024","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.117187_bib56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm0615-540","article-title":"Updated, augmented vaccines compete with original antigenic sin","volume":"21","author":"Chakradhar","year":"2015","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.biopha.2024.117187_bib57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2213907","article-title":"Antibody Response to Omicron BA.4-BA.5 Bivalent Booster","volume":"388","author":"Wang","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.117187_bib58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 Bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.117187_bib59","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/infdis\/jiad073","article-title":"Bivalent COVID-19 vaccines: can the original antigenic sin be forgiven?","volume":"227","author":"Blankson","year":"2023","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2024.117187_bib60","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2024.117187_bib61","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/infdis\/jiaa664","article-title":"Differences in influenza-specific CD4 T-cell mediated immunity following acute infection versus inactivated vaccination in children","volume":"223","author":"Shannon","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.117187_bib62","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.173.4.881","article-title":"Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells","volume":"173","author":"Klinman","year":"1991","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.biopha.2024.117187_bib63","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/590434","article-title":"Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial","volume":"198","author":"Holland","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117187_bib64","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.4049\/jimmunol.171.9.4765","article-title":"al. e: IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host","volume":"171","author":"Liu","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117187_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","article-title":"From original antigenic sin to the universal influenza virus vaccine","volume":"39","author":"Henry","year":"2018","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117187_bib66","first-page":"451","article-title":"Sexually transmitted infections","volume":"12","author":"Fuchs","year":"2014","journal-title":"J. Dtsch Dermatol. Ges."},{"issue":"10","key":"10.1016\/j.biopha.2024.117187_bib67","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1128\/IAI.71.10.6054-6057.2003","article-title":"Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum","volume":"71","author":"Leader","year":"2003","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2024.117187_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009753","article-title":"Longitudinal TprK profiling of in vivo and in vitro-propagated Treponema pallidum subsp. pallidum reveals accumulation of antigenic variants in absence of immune pressure","volume":"15","author":"Lin","year":"2021","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:22:36Z","timestamp":1777861356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224010710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":68,"alternative-id":["S0753332224010710"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117187","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Original antigenic sin: A potential double-edged effect for vaccine improvement","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117187"}}